2 completed, 1 not yet recruiting, 1 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Fresenius Kabi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck Nutrition counseling, Fresubin Supportan - Head &Amp;Amp; Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Anna Arthur, PhD | 15 | 2027-06-01 | 2026-08-07 |
| Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome Amoxicillin, Levofloxacin, Ofloxacin - Short Bowel Syndrome, Infection, Bacterial | Phase 1 | Unknown | Central Hospital, Nancy, France | 10 | 2022-12-09 | 2024-08-29 |
| Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients Ketosteril® - Renal Insufficiency, Chronic | Phase 1 / Phase 2 | Completed | Fresenius Kabi | 23 | 2017-03-30 | 2018-05-14 |
| Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects Fulvestrant - Healthy | Phase 1 | Completed | Fresenius Kabi | 266 | 2016-06-01 | 2017-03-09 |
Bacterial Infections (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Renal Insufficiency, Chronic (1) · Sarcopenia (1) · Short Bowel Syndrome (1)
Amoxicillin (1) · Fulvestrant (1) · Levofloxacin (1) · Ofloxacin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · ketosteril (1)
Canada (1) · Czechia (1) · France (1)
PMID 15530127, PMID 1559306, PMID 20094812, PMID 2292168, PMID 24667978, PMID 29127863, PMID 29556926, PMID 34579024, PMID 35170737, PMID 35565223, PMID 40449504, PMID 6699766, PMID 7619677, PMID 7924123, PMID 9724482
2016 (1)